New concepts for CML clonality

Oncotarget. 2013 Jan;4(1):7-8. doi: 10.18632/oncotarget.882.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Base Sequence
  • Benzamides / therapeutic use
  • Clone Cells / metabolism
  • Clone Cells / pathology
  • DNA Mutational Analysis
  • Drug Resistance, Neoplasm / drug effects
  • Drug Resistance, Neoplasm / genetics
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / genetics*
  • Humans
  • Imatinib Mesylate
  • Imidazoles / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Models, Genetic
  • Mutation*
  • Piperazines / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-abl / antagonists & inhibitors
  • Proto-Oncogene Proteins c-abl / genetics*
  • Pyridazines / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • BCR-ABL1 fusion protein, human
  • Benzamides
  • Imidazoles
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyridazines
  • Pyrimidines
  • ponatinib
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl
  • Proto-Oncogene Proteins c-abl